Evidence map›Paper›PMID 30699138›Full record

ArticlePloS one2019

Efficacy assessment of commercially available natural products and antibiotics, commonly used for mitigation of pathogenic Vibrio outbreaks in Ecuadorian Penaeus (Litopenaeus) vannamei hatcheries.

María Auxiliadora Sotomayor, Jessica Karina Reyes, Leda Restrepo, Cristóbal Domínguez-Borbor, Martha Maldonado, Bonny Bayot

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. ManagingMolecules (Basel, Switzerland) · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Live Feeds Used in the Larval Culture of Red Cusk Eel,Animals : an open access journal from MDPI · 2020
    Article
  13. Attenuation ofMicroorganisms · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María Auxiliadora SotomayorCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.ORCID 0000-0002-6032-220X
Jessica Karina ReyesCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.
Leda RestrepoCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.
Cristóbal Domínguez-BorborCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.ORCID 0000-0003-3204-3569
Martha MaldonadoCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.
Bonny BayotCentro Nacional de Acuicultura e Investigaciones Marinas, CENAIM. Escuela Superior Politécnica del Litoral, ESPOL, Guayaquil, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial diseases cause high mortality in Penaeus (Litopenaeus) vannamei postlarvae. Therefore, appropriate application of efficient therapeutic products is of vital importance for disease control. This study evaluated through in vitro analyses the antimicrobial effectiveness of commercial therapeutic products used for P. vannamei bacterial diseases and antibiotics against pathogenic Vibrio strains circulating in Ecuadorian hatcheries. Twenty strains were isolated from 31 larvae samples with high bacterial counts from 10 hatcheries collected during mortality events. The strains virulence was verified through challenge tests with Artemia franciscana nauplii and P. vannamei postlarvae. Through 16S rRNA sequence analysis, strains showed a great similarity to the Vibrio sequences reported as pathogens, with 95% belonging to the Harveyi clade. Through antibiograms and minimal inhibitory concentration (MIC) in vitro tests we found that furazolidone, ciprofloxacin, chloramphenicol, norfloxacin, nalidixic acid, florfenicol, fosfomycin and enrofloxacin inhibited the growth of all or most of the strains. Less efficient antibiotics were penicillin, oxytetracycline and tetracycline. A multiple antibiotic resistance (MAR) index of 0.23 showed some level of resistance to antibiotics, with two MAR prevalent patterns (Penicillin-Oxytetracycline and Penicillin-Oxytetracycline-Tetracycline). From a total of 16 natural products (five probiotics, nine organic acids and two essential oils), only three (one probiotic, one organic acid and one essential oil) were effective to control most of the strains. Shrimp producers can apply relatively simple in vitro analyses, such as those employed in this study, to help take adequate management decisions to reduce the impact of bacterial diseases and increase profit.

Indexed as

AquacultureAnimalsAnti-Bacterial AgentsBase SequenceBiological ProductsCarboxylic AcidsCell SurvivalDisease OutbreaksDrug Resistance, MicrobialEcuadorHemocytesMicrobial Sensitivity TestsOils, VolatilePenaeidaePhylogenyProbioticsAnti-Bacterial AgentsBiological ProductsCarboxylic AcidsOils, VolatileRNA, Ribosomal, 16S

Identifiers

PMID30699138
PMCPMC6353134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.